| Price | 79.00p on 14-11-2025 at 19:30:04 |
|---|---|
| Change | -2.90p -3.56% |
| Buy | 80.00p |
| Sell | 78.00p |
| Last Trade: | Sell 43,402.00 at 78.60p |
| Day's Volume: | 3,537,410 |
| Last Close: | 78.60p |
| Open: | 81.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 78.60p - 78.60p |
| 52wk Range: | 27.25p - 81.50p |
| Market Capitalisation: | £340.86m |
| VWAP: | 78.189p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 43,402 | 78.60p | Uncrossing Trade |
16:35:19 - 14-Nov-25 |
| Sell* | 1,279 | 78.5039p | Ordinary |
16:28:51 - 14-Nov-25 |
| Buy* | 12,968 | 79.80p | Ordinary |
16:28:37 - 14-Nov-25 |
| Sell* | 38 | 78.5039p | Ordinary |
16:27:56 - 14-Nov-25 |
| Buy* | 125 | 80.00p | Ordinary |
16:27:32 - 14-Nov-25 |
| Buy* | 5,523 | 80.00p | Ordinary |
16:24:39 - 14-Nov-25 |
| Sell* | 1,764 | 78.5039p | Ordinary |
16:23:43 - 14-Nov-25 |
| Sell* | 1,243 | 78.5039p | Ordinary |
16:23:38 - 14-Nov-25 |
| Sell* | 3,500 | 78.50p | Ordinary |
16:22:30 - 14-Nov-25 |
| Buy* | 4,369 | 79.80p | Ordinary |
16:18:50 - 14-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
